Position in PFE
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$978,490
-$455,920 QoQ
Shares Held
40,635
-20.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,343
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DEARBORN PARTNERS LLC holds $75,110,921 across 10 Drug Manufacturers - General names. PFE ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
114,591 | $28,835,679 | |
| 2 | JNJ |
Johnson & Johnson
|
79,895 | $20,290,932 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
67,003 | $8,465,159 | |
| 4 | LLY |
ELI LILLY & Co
|
4,621 | $5,542,566 | |
| 5 | NVS |
Novartis AG
|
32,039 | $5,021,152 | |
| 6 | MRK |
Merck & Co., Inc.
|
28,921 | $3,716,348 | |
| 7 | GSK |
GSK plc
|
23,142 | $1,213,103 | |
| 8 | PFE |
Pfizer Inc
This page
|
40,635 | $978,490 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $978,490 | 40,635 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $1,434,410 | 51,083 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,186,734 | 47,660 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,253,539 | 49,197 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $943,081 | 38,906 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $995,988 | 39,305 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $956,406 | 36,050 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,165,124 | 40,260 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,044,269 | 37,322 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $906,953 | 32,683 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $794,776 | 27,606 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $1,024,488 | 30,886 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,240,040 | 33,807 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,377,897 | 33,772 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,765,781 | 34,461 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,546,390 | 35,338 | Shares | Sole | 2022-11-21 | |
| 2022-06-30 | $1,941,325 | 37,027 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $1,912,797 | 36,948 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,019,923 | 34,207 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $1,551,800 | 36,080 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $1,294,903 | 33,067 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,200,336 | 33,131 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,228,165 | 33,365 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $1,263,653 | 34,432 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $1,170,759 | 35,803 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $1,169,359 | 35,826 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||